Trends and Challenges in Nitrosamine Testing: Part Five – Pharma’s Future
Our gurus return to discuss future directions for nitrosamine analysis and regulation within the pharmaceutical industry
Our gurus return to discuss future directions for nitrosamine analysis and regulation within the pharmaceutical industry
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
December 1, 2014
0 min read
The Galactic Grant Competition encourages companies to use the International Space Station for pharmaceutical R&D
December 1, 2014
0 min read
Researchers estimate the cost of drug development at over $1 billion, while others say it’s less than $100 million. Who’s right? And how can we accurately determine the true costs?
December 2, 2014
0 min read
Electrochemical reaction cells are finding new applications in the pharma R&D lab that could offer big time and cost savings...
December 2, 2014
0 min read
Sitting Down With… William Chin, Executive Vice President, Scientific and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA).
Affiliations:
Specialties:
Areas of Expertise: